# Treatment and Outcome of Early Onset Bipolar Disorder

> **NCT00048802** · PHASE4 · COMPLETED · sponsor: **Northwell Health** · enrollment: 40 (—)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** Lithium
- **DRUG:** Olanzapine
- **DRUG:** Divalproex
- **DRUG:** Risperidone
- **DRUG:** Quetiapine
- **DRUG:** Ziprasidone
- **DRUG:** Aripriprazole

## Key facts

- **NCT ID:** NCT00048802
- **Lead sponsor:** Northwell Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-08
- **Primary completion:** 2006-08
- **Final completion:** 2006-08
- **Target enrollment:** 40 (—)
- **Last updated:** 2014-01-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00048802

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00048802, "Treatment and Outcome of Early Onset Bipolar Disorder". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00048802. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*